Apigenin augments TRAIL-induced apoptosis in Jurkat leukemia cells, DU145 prostate cancer cells, and DLD-1 colon cancer cells through upregulation of TRAIL-R2 and activation of Bid and caspase-8, -10, -9, -3 [44]. Here, CASP8 is linked to prostate cancer.